1. bookVolume 49 (2022): Edizione 3 (October 2022)
Dettagli della rivista
License
Formato
Rivista
eISSN
2719-5384
Prima pubblicazione
05 Nov 2014
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

The Calcium Loading Test in Primary Hyperparathyroidism – Does it Provide Useful Information?

Pubblicato online: 26 Oct 2022
Volume & Edizione: Volume 49 (2022) - Edizione 3 (October 2022)
Pagine: 5 - 11
Ricevuto: 02 Sep 2022
Accettato: 20 Sep 2022
Dettagli della rivista
License
Formato
Rivista
eISSN
2719-5384
Prima pubblicazione
05 Nov 2014
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993-4004.10.1210/jc.2018-01225 Search in Google Scholar

2. Macfarlane DP, Yu N, Leese GP. Subclinical and asymptomatic parathyroid disease: implications of emerging data. Lancet Diab Endocrinol. 2013;1(4):329-340.10.1016/S2213-8587(13)70083-4 Search in Google Scholar

3. Borissova A-M, Vlahov JD, Krivoshiev SG et al. The prevalence of hyperparathyroidism in the Bulgarian population – Analysis of an epidemiological study by the Bulgarian Society of Endocrinology (BSE) – 2012. J Endocrinologia. 2019;24(4):202-212. Search in Google Scholar

4. Pawlowska M, Cusano NE. An overview of normocalcemic primary hyperparathyroidism. Curr Opin Endocrinol Diab Obes. 2015;22(6):413-421.10.1097/MED.000000000000019826512768 Search in Google Scholar

5. Kim JK, Chai YJ, Chung JK et al. The prevalence of primary hyperparathyroidism in Korea: a population-based analysis from patient medical records. Ann Surg Treat Res. 2018;94(5):235-239.10.4174/astr.2018.94.5.235593193329732354 Search in Google Scholar

6. Collier A, Portelli M, Ghosh S et al. Primary hyperparathyroidism: Increasing prevalence, social deprivation, and surgery. Endocr Res. 2017;42(1):31-35.10.3109/07435800.2016.1169545 Search in Google Scholar

7. Clark BL. Asymptomatic Primary Hyperparathyroidism. In: Brandi ML, ed. Parathyroid Disorders. Focusing on Unmet Needs. Frontiers of Hormone Research 51, Basel, Karger, 2019:13-22.10.1159/000491035 Search in Google Scholar

8. Souberbielle JC, Cavalier E, Cormier C. How to manage an isolated elevated PTH? Ann Endocrinol (Paris). 2015;76(2):134-141.10.1016/j.ando.2015.03.005 Search in Google Scholar

9. Lips P, Netelenbos JC, Doorn Lv et al. Stimulation and suppression of intact parathyroid hormone (PTH1–84) in normal subjects and hyperparathyroid patients. Clin Endocrinol. 1991;35(1):35-40.10.1111/j.1365-2265.1991.tb03493.x Search in Google Scholar

10. Zhu X, Shan C, Zhu Q et al. Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism. Int J Clin Exp Med. 2014;7(12):5445-5452. eCollection 2014. Search in Google Scholar

11. Malberti F, Farina M, Imbasciati E. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrol Dial Transpl. 1999;14(10):2398-2406.10.1093/ndt/14.10.239810528664 Search in Google Scholar

12. Keller EX, De Coninck V, Pietropaolo A et al. Metabolic evaluation: Place of the calcium load test: How, when, for whom, and why? Eur Urol Focus. 2021;7(1):26-30.10.1016/j.euf.2020.12.01933419710 Search in Google Scholar

13. Borissova AM, Shinkov A, Vlahov J et al. Prevalence of vitamin D deficiency, insufficiency and sufficiency in Bulgarian population aged 20-80 years. Endocrinologia. 2012;17(3):122-134. Search in Google Scholar

14. Reiss E, Canterbury JM. Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med. 1969;280(25):1381-1385.10.1056/NEJM1969061928025045771363 Search in Google Scholar

15. Murray TM, Peacock M, Powell D et al. Non-autonomy of hormone secretion in primary hyperparathyroidism. Clin Endocrinol (Oxf). 1972;1(3):235-246.10.1111/j.1365-2265.1972.tb00394.x4198020 Search in Google Scholar

16. Birnbaumer ME, Schneider AB, Palmer D et al. Secretion of parathyroid hormone by abnormal human parathyroid glands in vitro. J Clin Endocrinol Metab. 1977;45(1):105-113.10.1210/jcem-45-1-105874057 Search in Google Scholar

17. Broadus AE, Deftos LJ, Bartter FC. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test. J Clin Endocrinol Metab. 1978;46(3):477-487.10.1210/jcem-46-3-477221521 Search in Google Scholar

18. Sørensen HA, Schwarz P, McNair P et al. Calcium clamp technique: suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism. Scand J Clin Lab Invest. 1992;52(6):457-465.10.3109/003655192090901221411258 Search in Google Scholar

19. Titon I, Cailleux-Bounacer A, Basuyau JP et al. Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism. Eur J Endocrinol. 2007;157(3):351-357.10.1530/EJE-07-013217766719 Search in Google Scholar

20. Hagag P, Revet-Zak I, Hod N et al. Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test. J Endocrinol Invest. 2003;26(4):327-332.10.1007/BF0334518012841540 Search in Google Scholar

21. Zhao L, Zhang MJ, Zhao HY et al. PTH inhibition rate is useful in the detecti on of early-stage primary hyperparathyroidism. Clin Biochem. 2011;44(10-11):844-848.10.1016/j.clinbiochem.2011.03.14221524645 Search in Google Scholar

22. Rao SD, Bhadada SK, Parfitt MA. Parathyroid growth normal and abnormal. In: Bilezikian JP, ed. The Parathyroids: basic and clinical concepts. New York, Academic Press (Elsevier), 2015:258-278. Search in Google Scholar

23. Sklavenitis-Pistofidis R, Papaioannou O, Kotsa K. Primary hyperparathyroidism and the road to surgery: appraisal of the proceedings of the four international workshops (1990, 2002, 2008, 2014) on primary hyperparathyroidism. Hormones (Athens). 2015;14(2):201-210.10.14310/horm.2002.158126158652 Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo